GSK, Pfizer sue Hikma over clotting-drug patent; Valeant to relocate HQ to Quebec;

@FiercePharma: One big hit to script numbers: Seniors avoiding the doc, holding off on refills for cost reasons--BloombergMore | Follow @FiercePharma

> GlaxoSmithKline ($GSK) and Pfizer ($PFE) sued Hikma Pharmaceuticals alleging patent infringement as the Jordanian drugmaker prepares to launch a version of the blood-clotting drug argatroban. News

> Valeant Pharmaceuticals ($VRX) said it would relocate its global headquarters to Quebec from Montreal and will set up a new R&D center for dermatology nearby. Report

> The Texas Department of Criminal Justice won't disclose the size of its lethal-injection drug stocks, saying that the information would create risks to its suppliers. More

> Watson Pharmaceuticals ($WPI) said a U.S. District Court invalidated a patent on Sanctura XR, an overactive bladder treatment, a drug it's hoping to knock off. Report

> Adding Erbitux to standard chemotherapy didn't make a significant difference in survival for colon cancer patients who'd had surgery, a study found. Item

Biotech News

@FierceBiotech: AstraZeneca scouts new drug deals to silence a chorus of critics. Story | Follow @FierceBiotech

@JohnCFierce: Burrill counted up all the early-stage venture funds coming together and ID'd $2.6B over just a few weeks. Serious $$. Release | Follow @JohnCFierce

@RyanMFierce: In case you missed, device that can detect neural activity called iBrain in the spotlight, famous ALS patient outfitted: Article | Follow @RyanMFierce

> OvaScience grabs $37M B round for fertility treatments. News

> Billions in new venture cash targeted at early-stage biotech efforts. Article

Medical Devices News

@FierceMedDev: St Jude To Stop Selling Another Version Of Defibrillator Wires | Fox BusinessNews | Follow @FierceMedDev

> Study: Metal hips don't heighten cancer risks. Item

> Imaging boosts breast cancer finds. Story

> Bio-Rad founder dies; stock soars on sale spec. More

Drug Delivery News

> After Astellas fallout, Zogenix strikes deal with Battelle to market DosePro. Article

> Is ImmunoGen overvalued? Item

> INSYS and Aptar launch under-the-tongue delivery for cancer pain drug. More

> Novartis touts positive results for COPD inhalant. Report

Biomarkers News

> Biomarkers could tag breast cancer recurrence earlier. News

> DNA biomarker pinpoints hep B liver cancers. Story

> Survivin could be key to survival in pancreatic cancer. Article

> Allergy biomarkers could track treatment response. Item

And Finally... Scientists are questioning a flurry of media coverage about the utility of genetic sequencing. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.